Review
Published on 18 Sep 2024
N-terminal domain of androgen receptor is a major therapeutic barrier and potential pharmacological target for treating castration resistant prostate cancer: a comprehensive review
in Experimental Pharmacology and Drug Discovery
- 4,340 views
- 3 citations